Bio-Path Stock Price (NASDAQ:BPTH)

Add to My Stocks
$0.78 $0.02 (2.5%) BPTH stock closing price Mar 24, 2017 (Closing)
Prev Close* : $0.80
Market Cap:
$76.06M
Day Low: $0.77
52 Week Low: $0.70
Open: $0.79
Volume: 54943
Day High: $0.79
52 Week High: $3.19
Dividend:
N/A

Latest Stock Market News

Latest Articles

Bio-Path News - From Partners

BPTH Stockcharts

View BPTH PE ratio, PS ratio stocks charts and compare with peers.
BPTH Chart
Note: Compare Bio-Path stock price history with the index and industry peers.

BPTH Industry Peers

Company Price Change (%)
Catalyst Pharma (CPRX)1.70.02 (1.19%)
Contrafect (CFRX)20 (0%)
Ariad Pharma (ARIA)23.990 (0%)
Macrogenics (MGNX)17.930.05 (0.28%)
Seattle Genetics (SGEN)63.690.47 (0.74%)
Stemline Therapeutics (STML)8.450.05 (0.59%)
Pdl Biopharma (PDLI)1.980.05 (2.46%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)7.40.32 (4.52%)
Tesaro Inc (TSRO)1606.38 (4.15%)
Ignyta (RXDX)9.250.35 (3.93%)
Flexion Therapeutics (FLXN)27.271.02 (3.89%)
BioCryst Pharma (BCRX)8.7850.3 (3.53%)
Xencor (XNCR)24.530.82 (3.46%)
Infinity Pharma (INFI)3.30.1 (3.13%)
Top gainers from Medical-Drugs industry
* As of Mar 25, 2017
CompanyPriceChange (%)
MediWound (MDWD)6.40.27 (4.04%)
Nature's Sunshine Products (NATR)9.150.35 (3.68%)
Esperion Therapeutics (ESPR)38.941.46 (3.61%)
Merus Labs International (MSLI)0.860.03 (3.37%)
Concert Pharma (CNCE)17.3950.48 (2.68%)
GlycoMimetics (GLYC)5.560.12 (2.11%)
Aralez Pharma (ARLZ)2.190.04 (1.79%)
Top losers from Medical-Drugs industry
* As of Mar 25, 2017

Bio-Path Financial Statements

income statement20152014201320122011
Net Sales Or Revenues-----
Net Income-5.46M-4.51M-3.26M-2.58M-2.36M
Total Operating Expense5.48M4.53M3.26M2.57M2.36M
view Bio-Path Holdings Inc income statement
balance sheet20152014201320122011
Total Assets10.75M15.47M5.07M2.34M3.23M
Total Liabilities0.93M0.56M0.29M0.32M0.31M
Shareholders Equity9.81M14.91M4.78M2.01M2.91M
view Bio-Path Holdings Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-0.1M0.12M0.08M-0.02M0.27M
Net Cash From (Used By) Operating Activities-5M-3.81M-2.31M-1.99M-1.14M
Increase (Decrease) In Prop Plant And Equipment--0.12M---
view Bio-Path Holdings Inc cashflow statement

Bio-Path Stock Message Board

An investor needs to spend 0.78 to buy BPTH stock, as the closing Bio-Path stock price is 0.78. Stock price or share price can be used to find the total market value of a company. Bio-Path market cap stands at 76.06M as of 24 Mar, 2017. A value investor must look at the fundamentals of a stock, and perform Bio-Path valuation, even though in the short-term sentiment and current breaking news might affect Bio-Path stock price.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Bio-Path is worth a lot, it will most likely be reflected in an inflated Bio-Path stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 54943 shares were traded with a closing stock price of 0.78 as of 24 Mar, 2017, as can be seen from Bio-Path stock quote. One can view Bio-Path stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Bio-Path stock price history, gives the entire historical data for BPTH stock.